Erratum: The 2q23.1 microdeletion syndrome: Clinical and behavioural phenotype (European Journal of Human Genetics (2010) 18 (163-170) DOI: 10.1038/ejhg.2009.152);The 2q23.1 microdeletion syndrome: Clinical and behavioural phenotype

European Journal of Human Genetics

Volumn 18, Issue 2, 2010, Pages 163-170

  Van Bon, Bregje W M ^a   Koolen, David A ^a   Brueton, Louise ^b   McMullan, Dominic ^b   Lichtenbelt, Klaske D ^c   Adès, Lesley C ^d   Peters, Gregory ^d   Gibson, Kate ^e   Novara, Francesca ^f   Pramparo, Tiziano ^f   Bernardina, Bernardo Dalla ^g   Zoccante, Leonardo ^g   Balottin, Umberto ^g   Piazza, Fausta ^g   Pecile, Vanna ^h   Gasparini, Paolo ⁱ   Guerci, Veronica ⁱ   Kets, Marleen ^a   Pfundt, Rolph ^a   De Brouwer, Arjan P ^a   Veltman, Joris A ^a   De Leeuw, Nicole ^a   Wilson, Meredith ^j   Antony, Jayne ^j   Reitano, Santina ^k   Luciano, Daniela ^k   Fichera, Marco ^k   Romano, Corrado ^k   Brunner, Han G ^a   Zuffardi, Orsetta ^f,l   De Vries, Bert B A ^a   more..

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UNIVERSITY OF SYDNEY   (Australia)

^e ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^f UNIVERSITY OF PAVIA   (Italy)

^g UNIVERSITY OF VERONA   (Italy)

^h INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

ⁱ UNIVERSITY OF TRIESTE   (Italy)

^j CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^k OASI RESEARCH INSTITUTE IRCCS   (Italy)

^l C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

more..

Author keywords

2q23.1; Angelman; EPC2; MBD5; Microdeletion; Rett

Indexed keywords

ANTICONVULSIVE AGENT; CHROMOSOME PROTEIN; EPC2 PROTEIN; MELATONIN; METHYL CPG BINDING PROTEIN; METHYL CPG BINDING PROTEIN 5; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ATONIC SEIZURE; AUTOMUTILATION; BRAIN ATROPHY; CHILD; CHROMOSOME 2Q; CLINICAL ARTICLE; COARSE FACE; CONSTIPATION; CRYPTORCHISM; DIFFERENTIAL DIAGNOSIS; FACE DYSMORPHIA; FECES INCONTINENCE; FEMALE; FOLLOW UP; GAIT DISORDER; GENE DELETION; GROWTH RETARDATION; HAPPY PUPPET SYNDROME; HUMAN; HYPERPHAGIA; INFANT; LANGUAGE DISABILITY; MALE; MENTAL DEFICIENCY; MICROARRAY ANALYSIS; MICROCEPHALY; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; NEWBORN; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PSYCHOMOTOR RETARDATION; REAL TIME POLYMERASE CHAIN REACTION; RETT SYNDROME; SEIZURE; SHORT STATURE; SLEEP DISORDER; SMITH MAGENIS SYNDROME; STEREOTYPY;

EID: 74449084036     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2010.103     Document Type: Erratum

References (27)

1. Mefford HC, Sharp AJ, Baker C et al: Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes. N Engl J Med 2008; 359: 1685-1699.
2. Gajecka M, Mackay KL, Shaffer LG: Monosomy 1p36 deletion syndrome. Am J Med Genet C Semin Med Genet 2007; 145C: 346-356.
3. Koolen DA, Sharp AJ, Hurst JA et al: Clinical and molecular delineation of the 17q21.31 microdeletion syndrome. J Med Genet 2008; 45: 710-720.
4. Ben-Shachar S, Ou Z, Shaw CA et al: 22q11.2 distal deletion: a recurrent genomic disorder distinct from DiGeorge syndrome and velocardiofacial syndrome. Am J Hum Genet 2008; 82: 214-221.
5. Ballif BC, Hornor SA, Jenkins E et al: Discovery of a previously unrecognized microdeletion syndrome of 16p11.2-p12.2. Nat Genet 2007; 39: 1071-1073.
6. Ballif BC, Theisen A, Coppinger J et al: Expanding the clinical phenotype of the 3q29 microdeletion syndrome and characterization of the reciprocal microduplication. Mol Cytogenet 2008; 1: 8.
7. Sharp AJ, Selzer RR, Veltman JA et al: Characterization of a recurrent 15q24 microdeletion syndrome. Hum Mol Genet 2007; 16: 567-572.
8. Ullmann R, Turner G, Kirchhoff M et al: Array CGH identifies reciprocal 16p13.1 duplications and deletions that predispose to autism and/or mental retardation. Hum Mutat 2007; 28: 674-682.
9. Kleefstra T, Brunner HG, Amiel J et al: Loss-of-function mutations in euchromatin histone methyl transferase 1 (EHMT1) cause the 9q34 subtelomeric deletion syndrome. Am J Hum Genet 2006; 79: 370-377.
10. Petrij F, Giles RH, Dauwerse HG et al: Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature 1995; 376: 348-351.
11. Breuning MH, Dauwerse HG, Fugazza G et al: Rubinstein-Taybi syndrome caused by submicroscopic deletions within 16p13.3. Am J Hum Genet 1993; 52: 249-254.
12. Vissers LE, de Vries BB, Osoegawa K et al: Array-based comparative genomic hybridization for the genomewide detection of submicroscopic chromosomal abnormalities. Am J Hum Genet 2003; 73: 1261-1270.
13. Koolen DA, Vissers LE, Nillesen W et al: A novel microdeletion, del(2)(q22.3q23.3) in a mentally retarded patient, detected by array-based comparative genomic hybridization. Clin Genet 2004; 65: 429-432.
14. Jaillard S, Dubourg C, Gérard-Blanluet M et al: 2q23.1 microdeletion identified by array-CGH: an emerging phenotype with Angelman-like features? J Med Genet 2008 (e-pub ahead of print).
15. Wagenstaller J, Spranger S, Lorenz-Depiereux B et al: Copy-number variations measured by single-nucleotide-polymorphism oligonucleotide arrays in patients with mental retardation. Am J Hum Genet 2007; 81: 768-779.
16. De Gregori M, Ciccone R, Magini P et al: Cryptic deletions are a common finding in 'balanced' reciprocal and complex chromosome rearrangements: a study of 59 patients. J Med Genet 2007; 44: 750-762.
17. de Vries BB, Pfundt R, Leisink M et al: Diagnostic genome profiling in mental retardation. Am J Hum Genet 2005; 77: 606-616.
18. Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G: Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 2002; 30: e57.
19. Rozen S, Skaletsky H: Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000; 132: 365-386.
20. Marcelis CL, Hol FA, Graham GE et al: Genotype-phenotype correlations in MYCN-related Feingold syndrome. Hum Mutat 2008; 29: 1125-1132.
21. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408.
22. Clayton-Smith J, Laan L: Angelman syndrome: a review of the clinical and genetic aspects. J Med Genet 2003; 40: 87-95.
23. Gropman AL, Duncan WC, Smith AC: Neurologic and developmental features of the Smith-Magenis syndrome (del 17p11.2). Pediatr Neurol 2006; 34: 337-350.
24. Roloff TC, Ropers HH, Nuber UA: Comparative study of methyl-CpG-binding domain proteins. BMC Genomics 2003; 4: 1.
25. Doyon Y, Selleck W, Lane WS, Tan S, Cote J: Structural and functional conservation of the NuA4 histone acetyltransferase complex from yeast to humans. Mol Cell Biol 2004; 24: 1884-1896.
26. Perry J: The Epc-N domain: a predicted protein-protein interaction domain found in select chromatin associated proteins. BMC Genomics 2006; 7: 6.
27. Kramer JM, van BH: Genetic and epigenetic defects in mental retardation. Int J Biochem Cell Biol 2009; 41: 96-107.